Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 1,260 | 1,850 | 1,600 | 2,200 | 1,660 |
| Cost of Goods | 120 | 130 | 90 | 240 | 40 |
| Gross Profit | 1,140 | 1,720 | 1,500 | 1,950 | 1,610 |
| Operating Expenses | 1,740 | 1,830 | 1,900 | 1,830 | 1,190 |
| Operating Income | -480 | 20 | -300 | 370 | 470 |
| Interest Expense | 10 | 10 | 10 | 30 | 100 |
| Other Income | 0 | 0 | 70 | 50 | -10 |
| Pre-tax Income | -490 | 10 | -240 | 390 | 360 |
| Income Tax | 5 | -6 | -2 | 10 | 7 |
| Net Income Continuous | -495 | 16 | -238 | 380 | 353 |
| Net Income | $-490 | $10 | $-240 | $380 | $350 |
| EPS Basic Total Ops | -163,756.70 | 3,342.00 | -106,252.40 | 249,140.20 | 229,477.10 |
| EPS Basic Continuous Ops | -165,427.70 | 5,347.20 | -105,367.00 | 249,140.20 | 231,444.00 |
| EBITDA(a) | $-400 | $120 | $-170 | $450 | $570 |